Patients News | pharmaphorum

News

The money spent by the NHS on newly approved therapies recommended by NICE might have been better spent elsewhere, according to a new study.

News

Prominent podcaster Steven Bartlett has been accused of allowing health misinformation to be shared on his Diary of a CEO stream.

News

A study has confirmed that colorectal cancer is rising in younger adults around the world, with England among countries seeing the fastest rise.

News

Santhera's Duchenne muscular dystrophy (DMD) therapy Agamree has been cleared for NHS use after a confidential pricing agreement.

News

Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel.

News

Readout from NEXUS study sets up mid-2025 refiling for Minoryx and Neuraxpharm's leriglitazone for rare disease cerebral adrenoleukodystrophy (cALD).